Fundraising Fox
Guard Therapeutics
8 employees on LinkedIn · 1 known investors
Find your way into Guard Therapeutics
Sign up to see every warm intro you have to Guard Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Guard Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Disruptive Pharma AB (formerly Guard Therapeutics International AB) is a pharmaceutical company listed on Nasdaq First North Growth Market under the ticker DPHA. The page contains shareholder and stock information but does not describe the company's products, therapeutic focus, or target markets.
Founders & leadership
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountRights OfferingApr 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Guard Therapeutics do?
- Disruptive Pharma AB (formerly Guard Therapeutics International AB) is a pharmaceutical company listed on Nasdaq First North Growth Market under the ticker DPHA. The page contains shareholder and stock information but does not describe the company's products, therapeutic focus, or target markets.
- Who are Guard Therapeutics's investors?
- Guard Therapeutics's investors include Industrifonden.